These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24203450)

  • 1. Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
    Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Moline ML; Harris SC; Kapil RP
    J Clin Pharmacol; 2014 Mar; 54(3):282-90. PubMed ID: 24203450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
    Greenblatt DJ; Harmatz JS; Roth T; Singh NN; Moline ML; Harris SC; Kapil RP
    Clin Ther; 2013 May; 35(5):604-11. PubMed ID: 23541711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects.
    Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Harris SC; Kapil RP
    Drugs Aging; 2014 Oct; 31(10):731-6. PubMed ID: 25246162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.
    Greenblatt DJ; Harmatz JS; Singh NN; Roth T; Harris SC; Kapil RP
    J Clin Pharmacol; 2013 Nov; 53(11):1194-8. PubMed ID: 23939537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
    Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
    Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
    Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
    Roth T; Steinberg F; Singh NN; Moline M
    Hum Psychopharmacol; 2014 Jan; 29(1):25-30. PubMed ID: 24424704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Mertzanis P; Graf JA; Durol AL; Counihan M; Roth-Schechter B; Shader RI
    Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
    Giorgi M; Portela DA; Breghi G; Briganti A
    Am J Vet Res; 2012 Oct; 73(10):1650-6. PubMed ID: 23013193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
    Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.
    Cysneiros RM; Farkas D; Harmatz JS; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 2007 Jul; 82(1):54-62. PubMed ID: 17443132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem.
    Farkas D; Volak LP; Harmatz JS; von Moltke LL; Court MH; Greenblatt DJ
    Clin Pharmacol Ther; 2009 Jun; 85(6):644-50. PubMed ID: 19242403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Wright CE; Durol AL; Harrel-Joseph LM; Shader RI
    J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects.
    Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
    Br J Clin Pharmacol; 2007 Jan; 63(1):116-20. PubMed ID: 16822278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
    Roth T; Mayleben D; Corser BC; Singh NN
    Hum Psychopharmacol; 2008 Jan; 23(1):13-20. PubMed ID: 17907263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
    Stangier J; Rathgen K; Stähle H; Gansser D; Roth W
    Br J Clin Pharmacol; 2007 Sep; 64(3):292-303. PubMed ID: 17506785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers.
    Valente KD; Hasan R; Tavares SM; Gattaz WF
    Sleep Med; 2013 Jan; 14(1):20-3. PubMed ID: 23218533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
    Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
    Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.